Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GW Pharma Gets Big Analyst Upgrade Into Cannabinoid FDA Orphan Drug Designation
GW Pharma Gets Big Analyst Upgrade Into Cannabinoid FDA Orphan Drug Designation
GW Pharma Gets Big Analyst Upgrade Into Cannabinoid FDA Orphan Drug Designation
Submitted by
admin
on April 24, 2015 - 10:49am
Source:
24/7 Wall St
News Tags:
GW Pharma
Cannabidiol
Headline:
GW Pharma Gets Big Analyst Upgrade Into Cannabinoid FDA Orphan Drug Designation
Do Not Allow Advertisers to Use My Personal information